Gilead’s HIV franchise generated $19.612B in 2024, but faces future funding challenges. Learn why GILD stock is a "Hold" amid ...

Here is an overview of the Marion area's boys track season before it starts this weekend. See who looks strong for 2025.

The Post caught up with several stars and crew members of “The Handmaid’s Tale” at the show’s sixth and final season premiere ...

The Town pays $400,000 to send 18 Gilead children to school, said Town Clerk Patsy Cox, who added that they would not have a ...

"We tried not to make the same show — it's got younger voices, it's got a completely different feel and a completely ...

As the sixth and final season lands on Hulu, THR’s chief TV critic reflects on how the dystopian series was shaped by the ...

The final season of "The Handmaid's Tale," premiering April 8 on Hulu, expands the themes and story of Margaret Atwood's ...

She hasn’t just starred as the rebel June Osborne since the beginning of the series. Moss has directed several episodes of ...

PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...

In the latest market close, Gilead Sciences (GILD) reached $112.39, with a +0.45% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 4.84%. On ...

Elisabeth Moss and Yvonne Strahovski still shine in the final chapters of the dystopian thriller "The Handmaid's Tale" ...

Three other Bay Area companies — Mirum Therapeutics Inc. (Nasdaq: MIRM), Soleno Therapeutics Inc. (Nasdaq: SLNO) and Exelixis ...